Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Rapha Capital Management Participates In Series C Financing For Poseida Therapeutics, Inc. Led By Novartis Pharmaceuticals
LPNEWS

Rapha Capital Management Participates In Series C Financing For Poseida Therapeutics, Inc. Led By Novartis Pharmaceuticals

by vcaonline.com posted 1month ago 141 views
Rapha Capital Management Participates in Series C Financing for Poseida Therapeutics, Inc. Led by Novartis Pharmaceuticals MIAMI, April 22, 2019-- Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, and their associated entities announced today their participation in a Series C financing for Poseida Therapeutics ("Poseida"). The investment round was led by Novartis Pharma, AG, who were joined by new institutional investors and those with current positions in the company.

In this article